Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.61 |
| ▸ | LMNA | P02545 | 4/20 | 0.61 |
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.40 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.40 |
| ▸ | GMNN | O75496 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | THPO | P40225 | 1/20 | 0.40 |
| ▸ | MTOR | P42345 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17526642 | 1.00 | ALDH1A1 (0.61) | ALDH1A1LMNACA2TDP1SMN1; SMN2 | |
| SCHEMBL17526497 | 1.00 | ALDH1A1 (0.61) | ALDH1A1LMNACA2TDP1SMN1; SMN2 | |
| SCHEMBL17526754 | 0.97 | LMNA (0.65) | ALDH1A1LMNACA2TDP1SMN1; SMN2 | |
| SCHEMBL3101113 | 0.97 | LMNA (0.65) | ALDH1A1LMNACA2TDP1SMN1; SMN2 | |
| SCHEMBL2868648 | 0.97 | LMNA (0.65) | ALDH1A1LMNACA2TDP1SMN1; SMN2 | |
| SCHEMBL234696 | 0.97 | LMNA (0.65) | ALDH1A1LMNACA2TDP1SMN1; SMN2 | |
| SCHEMBL20679026 | 0.97 | LMNA (0.65) | ALDH1A1LMNACA2TDP1SMN1; SMN2 | |
| SCHEMBL6440282 | 0.97 | LMNA (0.65) | ALDH1A1LMNACA2TDP1SMN1; SMN2 | |
| SCHEMBL17526390 | 0.97 | LMNA (0.65) | ALDH1A1LMNACA2TDP1SMN1; SMN2 | |
| Methylamine SCHEMBL27841629 | 0.95 | ALDH1A1 (0.56) | ALDH1A1LMNACA2TDP1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250375392-A1 | Branched Tail Lipids and Uses Thereof | UNIV CARNEGIE MELLON (US) | 2025-12-11 | — | — | US | disclosed |
| EP-3558903-B1 | PROCESS FOR PHOSPHORYLATING A COMPLEX ALCOHOL | AVECHO BIOTECHNOLOGY LTD (AU) | 2024-07-03 | — | — | EP | disclosed |
| WO-2023223888-A1 | METHOD FOR PRODUCING POLYCARBONATE RESIN, AND ALICYCLIC POLYCARBONATE RESIN | 旭化成株式会社 | 2023-11-23 | — | — | WO | disclosed |
| US-11753435-B2 | Process | AVECHO BIOTECHNOLOGY LIMITED (AU) | 2023-09-12 | — | — | US | disclosed |
| EP-4224243-A1 | SPECTACLE LENS | Hoya Lens Thailand Ltd. (TH) | 2023-08-09 | — | — | EP | disclosed |
| US-20230116314-A1 | SPECTACLE LENS | HOYA LENS THAILAND LTD. (TH) | 2023-04-13 | — | — | US | disclosed |
| CN-115769131-A | Glasses lens | 豪雅镜片泰国有限公司 | 2023-03-07 | — | — | CN | disclosed |
| WO-2022071482-A1 | SPECTACLE LENS | ホヤ レンズ タイランド リミテッド | 2022-04-07 | — | — | WO | disclosed |
| US-20220106353-A1 | PROCESS | AVECHO BIOTECHNOLOGY LIMITED (AU) | 2022-04-07 | — | — | US | disclosed |
| CN-109721723-B | Surfactant, method for producing the same, and solution containing the same | 中日合成化学股份有限公司 | 2021-07-06 | — | — | CN | disclosed |
| US-5880147-A | Amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prohylactic use | SANKYO COMPANY, LIMITED (JP) | 1999-03-09 | — | — | US | disclosed |
| CN-1037268-C | Antipicornaviral pyridazinamines | JANSSEM PHARMACEUTICA N V (BE) | 1998-02-04 | — | — | CN | disclosed |
| US-5691319-A | ANTICARCINOGENIC AGENTS | SANKYO COMPANY, LIMITED (JP) | 1997-11-25 | — | — | US | disclosed |
| US-5614550-A | ANTICHOLESTEROL AGENTS OR ARTERIOSCLEROSIS AGENTS FOR HUMANS | SANKYO COMPANY, LIMITED (JP) | 1997-03-25 | — | — | US | disclosed |
| EP-0763524-A1 | Urea and amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use | SANKYO COMPANY LIMITED (JP) | 1997-03-19 | — | — | EP | disclosed |
| EP-0536936-B1 | Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use | SANKYO CO (JP) | 1996-08-14 | — | — | EP | disclosed |
| US-5534529-A | Substituted aromatic amides and ureas derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses | SANKYO COMPANY, LIMITED (JP) | 1996-07-09 | — | — | US | disclosed |
| EP-0632036-A2 | Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses | SANKYO COMPANY LIMITED (JP) | 1995-01-04 | — | — | EP | disclosed |
| EP-0536936-A1 | Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use | Sankyo Company Limited (JP) | 1993-04-14 | — | — | EP | disclosed |
| CN-1052857-A | The preparation method of the pyridazine amine that antipicornaviral is used | JANSSEN PHARMACEUTICA NV (BE) | 1991-07-10 | — | — | CN | disclosed |